argenx SE | Results Presentation Deck | 15 slides

front_matter

Open slide detail

Includes a hub-and-spoke diagram illustrating the effects of pathogenic autoantibodies.diagnose_problem

Open slide detailBeat · Problem Identification

The slide uses a visual process flow to explain the competitive inhibition mechanism.present_solution

Open slide detail

The slide uses a timeline-based process flow to illustrate the clinical trial protocol.present_framework

Open slide detail

Standard clinical trial participant flow diagram.illustrate_case

Open slide detail

Red boxes highlight key clinical history metrics: time since diagnosis, splenectomy history, prior therapies, and concurrent therapy usage.analyze_data

Open slide detailBeat · Agitation

The slide uses a hierarchical testing procedure for statistical significance.analyze_data

Open slide detailBeat · Solution

The chart includes error bars and a table of participant counts at the bottom.analyze_data

Open slide detailBeat · Before-After Comparison

The slide uses a stacked bar chart to visualize the response rates and a table to detail specific IWG criteria outcomes.analyze_data

Open slide detailBeat · Comparative Analysis

The chart uses a back-to-back bar structure to visualize the distribution of disease control duration.analyze_data

Open slide detail

The chart displays point estimates and 95% confidence intervals for the treatment effect across multiple clinical and demographic categories.analyze_data

Open slide detailLoop · Mece Breakdown

The chart displays a significant, sustained reduction in IgG levels for the treatment group compared to placebo.analyze_data

Open slide detail

The table compares adverse events (TEAEs) and specific common events between treatment and placebo groups.analyze_data